Stimulation of sensitivity of the glycogen phosphorylase-converting system in skeletal muscle by metabolic inhibitors.
D000818:Animals; D001059:Apoproteins / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology; D003964:Diaphragm; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005463:Fluoroacetates / Q000494:pharmacology; D006006:Glycogen Synthase / Q000378:metabolism; D007461:Iodoacetates / Q000494:pharmacology; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000201:enzymology*; D006005:Phosphorylases / Q000378:metabolism*; D011773:Pyruvates / Q000494:pharmacology; D051381:Rats
D001059:Apoproteins; D005463:Fluoroacetates; D007461:Iodoacetates; D011773:Pyruvates; D000242:Cyclic AMP; D006005:Phosphorylases; D006006:Glycogen Synthase; D004837:Epinephrine